Eyenovia, inc. (EYEN)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Operating Expenses:
Research and development

13,727

14,102

14,903

14,189

13,033

11,119

8,577

6,660

4,999

3,816

0

0

0

General and administrative

7,100

7,206

7,299

7,642

6,742

6,137

4,659

3,141

2,457

1,315

0

0

0

Total Operating Expenses

20,827

21,308

22,203

21,832

19,776

17,256

13,236

9,801

7,457

5,132

0

0

0

Loss From Operations

-20,827

-21,308

-22,203

-21,832

-19,776

-17,256

-13,236

-9,801

-7,457

-5,132

0

0

0

Other Income:
Interest expense

0

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

156

151

104

62

20

3

0

0

0

-

0

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

0

0

Net Loss

-20,675

-21,156

-22,098

-21,770

-19,755

-17,253

-13,232

-9,795

-7,453

-5,129

0

0

0

Net Loss Per Share
- Basic and Diluted

-0.31

-0.24

-0.29

-0.44

-0.50

-0.61

-0.43

-0.33

-0.45

-1.17

-0.10

-0.43

-0.49

Weighted Average Number of Common Shares Outstanding
- Basic and Diluted

17,308

17,173

16,270

12,034

11,919

10,315

10,030

9,998

7,561

-3,669

8,514

2,266

2,266